158 related articles for article (PubMed ID: 28927034)
1. Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation.
Lee SH; Wang X; Kim SH; Kim Y; Rodriguez-Puebla ML
Oncol Lett; 2017 Sep; 14(3):2723-2734. PubMed ID: 28927034
[TBL] [Abstract][Full Text] [Related]
2. Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.
Wang X; Sistrunk C; Rodriguez-Puebla ML
Am J Pathol; 2011 Jan; 178(1):345-54. PubMed ID: 21224071
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.
Wang X; Sistrunk C; Miliani de Marval PL; Kim Y; Rodriguez-Puebla ML
Cell Cycle; 2012 Jan; 11(2):335-42. PubMed ID: 22214766
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML
Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339
[TBL] [Abstract][Full Text] [Related]
5. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
6. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.
Rodriguez-Puebla ML; Miliani de Marval PL; LaCava M; Moons DS; Kiyokawa H; Conti CJ
Am J Pathol; 2002 Aug; 161(2):405-11. PubMed ID: 12163365
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
Chen Q; Lin J; Jinno S; Okayama H
Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
[TBL] [Abstract][Full Text] [Related]
8. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
9. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes.
Gonzales AJ; Goldsworthy TL; Fox TR
Carcinogenesis; 1998 Jun; 19(6):1093-102. PubMed ID: 9667749
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 overexpression in mouse epidermis increases cyclin-dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development.
Rodriguez-Puebla ML; LaCava M; Conti CJ
Cell Growth Differ; 1999 Jul; 10(7):467-72. PubMed ID: 10437914
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
12. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
[TBL] [Abstract][Full Text] [Related]
13. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
[TBL] [Abstract][Full Text] [Related]
16. Enhanced malignant tumorigenesis in Cdk4 transgenic mice.
Miliani de Marval PL; Macias E; Conti CJ; Rodriguez-Puebla ML
Oncogene; 2004 Mar; 23(10):1863-73. PubMed ID: 14647432
[TBL] [Abstract][Full Text] [Related]
17. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence.
Lin J; Jinno S; Okayama H
Oncogene; 2001 Apr; 20(16):2000-9. PubMed ID: 11360184
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
[TBL] [Abstract][Full Text] [Related]
19. CDK4 activity in mouse embryos expressing a single D-type cyclin.
Ciemerych MA; Yu Q; Szczepanska K; Sicinski P
Int J Dev Biol; 2008; 52(2-3):299-305. PubMed ID: 18311721
[TBL] [Abstract][Full Text] [Related]
20. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
